Rekombinanter TNF alpha (Humicade Biosimilar) Antikörper

Produktnummer ABIN5668143

Produktdetails

Target: TNF alpha (Humicade Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Human

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA

Verwendungszweck: Anti-TNF alpha [CDP 571 (Humicade)], Human IgG4, kappa

Spezifität: The antibody binds to human TNF-alpha with a Kd of 0.087 nM.

Produktmerkmale:

Original Species of Ab: Human

Original Format of Ab: IgG4

Aufreinigung: Protein A affinity purified

Reinheit: > 98 % as determined by SDS-PAGE

Endotoxin-Niveau: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Human TNF-alpha

Klon: CDP 571

Isotyp: IgG4 kappa

Anwendungsinformationen

Applikationshinweise: The antibody binds specifically to TNF-alpha, a pro-inflammatory cytokine which stimulates release of other cytiokines e.g. IL-1, IL-6 and GM-CSF as well as secretion of ICAM-1 and VCAM-1 from endothelial cells. It stimulates acute phase responses and acts as a chemoattractant for NK cells and monocytes/macrophages. The antibody reached Phase II clinical trials with Celltech, UCB.

Kommentare:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Antigendetails

Target: TNF alpha (Humicade Biosimilar)

Substanzklasse: Biosimilar

Hintergrund: TNFA, Tumour necrosis factor superfamily member 2, TNFSF2

UniProt: P01375